Your browser doesn't support javascript.
loading
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.
Britten, Carolyn D; Garrett-Mayer, Elizabeth; Chin, Steven H; Shirai, Keisuke; Ogretmen, Besim; Bentz, Tricia A; Brisendine, Alan; Anderton, Kate; Cusack, Susan L; Maines, Lynn W; Zhuang, Yan; Smith, Charles D; Thomas, Melanie B.
Afiliação
  • Britten CD; Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
  • Garrett-Mayer E; Department of Population Sciences, Medical University of South Carolina, Charleston, South Carolina.
  • Chin SH; Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
  • Shirai K; Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
  • Ogretmen B; Department of Biochemistry & Molecular Biology, Medical University of South Carolina, Charleston, South Carolina.
  • Bentz TA; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina.
  • Brisendine A; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina.
  • Anderton K; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina.
  • Cusack SL; Apogee Biotechnology Corporation, Hummelstown, Pennsylvania.
  • Maines LW; Apogee Biotechnology Corporation, Hummelstown, Pennsylvania.
  • Zhuang Y; Apogee Biotechnology Corporation, Hummelstown, Pennsylvania.
  • Smith CD; Apogee Biotechnology Corporation, Hummelstown, Pennsylvania. cdsmith@apogee-biotech.com.
  • Thomas MB; Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Clin Cancer Res ; 23(16): 4642-4650, 2017 Aug 15.
Article em En | MEDLINE | ID: mdl-28420720

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Adamantano / Fosfotransferases (Aceptor do Grupo Álcool) / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Adamantano / Fosfotransferases (Aceptor do Grupo Álcool) / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article
...